Precision BioSciences director RSUs vest into shares

PRECISION BIOSCIENCES INC director Stanley Frankel reported the vesting of equity awards, rather than an open-market trade.

Rhea-AI Filing Summary

PRECISION BIOSCIENCES INC director Stanley Frankel reported the vesting of equity awards, rather than an open-market trade. On May 20, 2026, 21,000 Restricted Stock Units (RSUs) converted into the same number of shares of common stock at an exercise price of $0.00 per share.

These RSUs were originally granted on June 3, 2025 and vested based on continued service and the timing of the company’s next annual stockholders’ meeting. Following this vesting event, Frankel directly holds 40,478 shares of Precision BioSciences common stock. The filing does not show any same-day sale of these shares, so this appears to be a routine compensation-related equity vesting and exercise.

Insider Trade Summary

21,000 shares exercised/converted

Exercise 2 txns

Insider Frankel Stanley

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	21,000	$0.00	$0.00
Exercise	Common Stock	21,000	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Common Stock — 40,478 shares (Direct)

Footnotes (3)

1. F1. Represents the vesting of Restricted Stock Units ("RSUs") on May 20, 2026.
2. F2. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
3. F3. On June 3, 2025 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Key Figures

RSUs vested: 21,000 units Common shares received: 21,000 shares Exercise price: $0.00 per share +2 more

5 metrics

RSUs vested 21,000 units Restricted Stock Units converted into common stock on May 20, 2026

Common shares received 21,000 shares Shares of common stock issued upon RSU vesting

Exercise price $0.00 per share Conversion of RSUs into common stock

Shares held after transaction 40,478 shares Director’s direct holdings following May 20, 2026 vesting

RSU grant date June 3, 2025 Original grant date of vested Restricted Stock Units

Key Terms

Restricted Stock Units, contingent right, annual meeting of stockholders, continued service

4 terms

Restricted Stock Units financial

"Represents the vesting of Restricted Stock Units ("RSUs") on May 20, 2026."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."

annual meeting of stockholders financial

"the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date"

continued service financial

"subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Precision BioSciences (DTIL) report for Stanley Frankel?

Precision BioSciences reported that director Stanley Frankel had 21,000 RSUs vest and convert into common stock. This is a compensation-related equity vesting, not an open-market purchase or sale of shares.

How many Precision BioSciences (DTIL) shares did Stanley Frankel receive from RSU vesting?

Stanley Frankel received 21,000 shares of Precision BioSciences common stock from the vesting of 21,000 Restricted Stock Units. Each RSU represented a contingent right to receive one share of common stock upon vesting.

What are Stanley Frankel’s total Precision BioSciences (DTIL) holdings after this Form 4?

After the RSU vesting, Stanley Frankel directly holds 40,478 shares of Precision BioSciences common stock. This reflects his position following the conversion of 21,000 Restricted Stock Units into common shares on May 20, 2026.

Were any Precision BioSciences (DTIL) shares sold in this Form 4 transaction?

No shares were reported as sold. The Form 4 shows RSUs vesting and converting into 21,000 shares of common stock at a $0.00 exercise price, with no same-day sale transactions disclosed.

When were the Precision BioSciences (DTIL) RSUs granted and when did they vest?

The RSUs were granted on June 3, 2025 and vested on May 20, 2026. Vesting occurred on the earlier of June 3, 2026 or the day before the company’s next annual stockholders’ meeting, subject to continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 07:31 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Frankel Stanley

(Last) (First) (Middle)

C/O PRECISION BIOSCIENCES, INC.

302 E. PETTIGREW ST., SUITE A-100

(Street)

DURHAM NORTH CAROLINA 27701

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECISION BIOSCIENCES INC [ DTIL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026		M		21,000(1)	A	(2)	40,478	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	05/20/2026		M			21,000	(3)	(3)	Common Stock	21,000	$0	0	D

Explanation of Responses:

1. Represents the vesting of Restricted Stock Units ("RSUs") on May 20, 2026.

2. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

3. On June 3, 2025 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Remarks:

	/s/ Dario Scimeca, Attorney-in-Fact for Stanley R. Frankel	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)